NL-OMON56002招募中2 期
Improving therapeutic ratio with hypofractionated stereotactic radiotherapy for brain metastases. - SAFESTEREO
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >= 18 years
- •- At least one brain metastasis of large cell cancer suitable for SRT
- •- Karnofsky Performance Status >= 70
- •- Ability to provide written informed consent
- •- Previous systemic therapy for brain metastases allowed
- •- New brain metastases during follow-up after surgery allowed (outside
- •resection cavity)
排除标准
- •- Contra-indication for MRI scan
- •- Primary tumor of small cell lung cancer, germinoma or lymphoma
- •- Prior whole brain radiotherapy or SRT on the current target brain metastases
- •(BM) (in field re-irradiation; salvage SRT of non-irradiated BM allowed if
- •radiation dose from previous irradiation in current target field is <1.0 Gy)
- •- The presence of leptomeningeal metastases
- •- Previous inclusion in the SAFESTEREO study
- •-Active bleeding metastases
研究者
相似试验
已完成
不适用
A clinical study on the safety of Hypofractionated Whole Breast Irradiation with Concurrent Boost in Breast conserving therapyBreast CancerJPRN-UMIN000018240Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University15
已完成
不适用
To study the safety and efficacy of hypofractionated intensity modulated radiotherapy for patients with intermediate-risk prostate cancer.prostate cancerJPRN-UMIN000003218Department of Radiation Oncology, The Cancer Institute Hospita, the Japanese Fundation for Cancer Reseach30
招募中
2 期
A study on the safety and efficacy of hypofractionated radiotherapy in post-operative irradiation for breast cancer patientsBreast cancerJPRN-UMIN000010977ational Institute of Radiological Sciences400
已完成
1 期
Clinical Trial for Hypofractionated (4 Fraction) Heavy Ion Therapy for Ocular / Choroidal MelanomaOcular / Choroidal MelanomaJPRN-UMIN000022302ational Institutes for Quantum and Radiological Science and Technology National Institute of Radiological Sciences30
招募中
不适用
HePro-TrialIntensity-modulated, hypofractionated radiotherapy with protons for hepatocellular carcinomas - a pilot studyHepatocellular Carcinoma (HCC)DRKS00025800niversitätsklinikum Essen, Klinik für Partikeltherapie, Westdeutsches Protonentherapiezentrum Essen (WPE)50